Trump's Health Appointees Stir Controversy Over Marijuana Stance

President-elect Donald Trump's nominee for FDA commissioner, Marty Makary, is a skeptic of medical marijuana, citing concerns about its potential as a gateway drug and its links to cardiovascular and mental health issues, particularly in youth. While Trump's HHS pick, Robert F. Kennedy Jr., supports cannabis reform, Makary's stance could influence federal cannabis policy, including drug rescheduling decisions. His views contrast with the growing trend of marijuana legalization across the U.S., raising uncertainty about the future of cannabis policy under the Trump administration.